Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss after a hypocaloric diet

Metabolism: Clinical and Experimental

Volumn 60, Issue 5, 2011, Pages 730-734

  De Luis, Daniel Antonio ^a   Gonzalez Sagrado, Manuel ^a   Aller, Rocio ^a   Izaola, Olatz ^a   Conde, Rosa ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID; FATTY ACID AMIDASE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; AMIDOHYDROLASES; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; CALORIC RESTRICTION; CHOLESTEROL; CHOLESTEROL, LDL; ENDOCANNABINOIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; OBESITY; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 79955044160     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.07.007     Document Type: Article

References (22)

1. Nguyen D.M., and El-Serag H.B. The epidemiology of obesity Gastroenterol Clin North Am 39 2010 1 7
2. de Luis D.A., Aller R., Izaola O., González Sagrado M., Conde R., and Perez Castrillon J.L. Effects of lifestyle modification on adipocytokine levels in obese patients Eur Rev Med Pharmacol Sci 12 2008 33 39 (Pubitemid 351425353)
3. Ameri A. The effects of cannabinnoids on the brain Prog Neurobiol 58 1999 315 348
4. Cravatt B.F., Giang D.K., MayWeld S.P., Boger D.L., Lerner R.A., and Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87 (Pubitemid 26374593)
5. Ueda N., PuVenbarger R.A., Yamamoto S., and Deutsch D.G. The fatty acid amide hydrolase (FAAH) Chem Phys Lipids 108 2000 107 121
6. McKinney M.K., and Cravatt B.F. Structure and function of fatty acid amide hydrolase Annu Rev Biochem 74 2005 411 432 (Pubitemid 40995513)
7. Lichtman A.H., Hawkins E.G., Griffin G., and Cravatt B.F. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo Pharmacol Exp Ther 302 2002 73 79 (Pubitemid 34680423)
8. Sipe J.C., Chiang K., Gerber A.L., Beutler E., and Cravatt B.F. A missense mutation in human fatty acid amide hydroxylase associated with problem drug abuse Proc Natl Acad Sci USA 99 2002 8394 8399 (Pubitemid 34651063)
9. Sipe J.C., Waalen J., Gerber A., and Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH) Int J Obes 29 2005 755 759 (Pubitemid 40897010)
10. Monteleone P., Tortorella A., Martiadis V., Filippo C., Canestrelli B., and Maj M. The CDNA 385 C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women Psychoneuroendocrinology 33 2008 546 550
11. Jensen D., Andreasen C., Andersen M., Hansen L., Eiberg H., and Borch-Johnsen K. The functional pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5801 whites J Mol Med 85 2007 445 449 (Pubitemid 46701653)
12. Aberle J., Fedderwitz I., Klages N., George E., and Beil F.U. Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet Horm Metab Res 39 2007 395 397 (Pubitemid 46887247)
13. Duart M.J., Arroyo C.O., and Moreno J.L. Validation of a insulin model for the reactions in RIA Clin Chem Lab Med 40 2002 1161 1167 (Pubitemid 36024452)
14. Mathews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., and Treacher D.F. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 414
15. Feurer I.D., and Mullen J.L. Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry Nutr Clin Pract 1 1986 43 49
16. Pichard C., Slosman D., Hirschel B., and Kyle U. Bioimpedance analysis: an improved method for nutritional follow up Clin Res 41 1993 53
17. Mataix J., and Mañas M. Tablas de composición de alimentos españoles 2003 University of Granada
18. Chiang K.P., Gerber A.L., Sipe J.C., and Cravatt B.F. Reduced cellular expression and activity of the P129T mutant fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use Hum Mol Genet 13 2004 2113 2119 (Pubitemid 39377833)
19. Papazoglou D., Panagopoulos I., Papanas N., Gioka T., Papadopoulos T., and Papathanasiou P. The FAAH Pro129Thr polymorphism is not associated with severe obesity in Greek Subjects Horm Metab Res 40 2008 907 910
20. Cota D., Marsicano G., Lutz B., Vicennatu V., Stalla G.K., and Pasqualli R. Endogenous cannabinoid system as a modulator of food intake Int J Obes Relat Metab Disor 27 2003 289 301 (Pubitemid 36384865)
21. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., and Jarai Z. Leptin. Regulated endocannabinoids are involved in maintaining food intake Nature 410 2001 822 825 (Pubitemid 32303781)
22. Egertova M., Cravatt B.F., and Elphick M.R. Comparative analysis of FAAH and CB1 canabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signalling Neuroscience 119 2003 481 496 (Pubitemid 36588826)